HomeRVMD • NASDAQ
add
Revolution Medicines Inc
Previous close
$46.24
Day range
$45.18 - $47.04
Year range
$29.17 - $62.40
Market cap
8.70B USD
Avg Volume
2.03M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 245.59M | 70.70% |
Net income | -247.79M | -85.98% |
Net profit margin | — | — |
Earnings per share | -1.31 | -61.73% |
EBITDA | -262.89M | -69.68% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.14B | 34.35% |
Total assets | 2.43B | 34.35% |
Total liabilities | 564.20M | 197.59% |
Total equity | 1.87B | — |
Shares outstanding | 186.93M | — |
Price to book | 4.63 | — |
Return on assets | -27.60% | — |
Return on capital | -31.43% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -247.79M | -85.98% |
Cash from operations | -221.76M | -73.02% |
Cash from investing | 34.28M | -68.25% |
Cash from financing | 256.58M | 3,319.28% |
Net change in cash | 69.10M | 643.30% |
Free cash flow | -121.80M | -63.19% |
About
Founded
2014
Headquarters
Website
Employees
700